Lymphangitis carcinomatosis as a potential predictor for a response to gefitinib.
Naito
T
T
Hasegawa
H
H
Asada
K
K
Suda
T
T
Chida
K
K
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002277:Carcinoma; D005260:Female; D005544:Forecasting; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008205:Lymphangitis; D008297:Male; D011799:Quinazolines / Q000494:pharmacology*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib